MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3960/jslrt.51.29

Медицинская библиотека · Journal of clinical and experimental hematopathology : JCEH · 2011

Comparison of long-term clinical outcomes of CHOP chemotherapy between Japanese patients with nodal peripheral T-cell lymphomas and those with diffuse large B-cell lymphoma in the study group of the Tohoku Hematology Forum.

Akagi Tomoaki, Takahashi Naoto, Yamaguchi Kouhei, Ishizawa Kenichi, Murai Kazunori, Tajima Katsushi, Ikeda Kazuhiko, Kameoka Yoshihiro, Kameoka Junnichi, Ito Shigeki, Kato Yuichi, Noji Hideyoshi, Shichishima Tsutomu, Itoh Jugoh, Ichinohasama Ryo, Harigae Hideo, Ishida Yoji, Sawada Kenichi

Сравнительное исследованиеСтатьяПеревод в очереди

Аннотация

To clarify the clinical outcome of peripheral T-cell lymphomas (PTCLs), we conducted a retrospective review comparing the outcomes of patients with PTCL (nodal peripheral T-cell lymphoma, unspecified, n=34 ; angioimmunoblastic T-cell lymphoma, n=12) to those with diffuse large B-cell lymphoma (DLBCL, n=48). All patients received CHOP-based chemotherapy without rituximab. PTCL patients presented at a more advanced clinical stage (91% vs. 65%, P<0.002) with a poorer performance status (26% vs. 17%, P<0.002) than DLBCL patients. The complete response rate among PTCL patients was significantly lower than among DLBCL patients (39% vs. 67%, P<0.008), as was the 3-year overall survival rate (26% vs. 50%, P=0.005), and Cox multivariate analysis revealed immunophenotype, performance status, and extranodal site involved to be significantly associated with shorter overall survival (P=0.045, P=0.007, and P=0.034, respectively). Our findings suggest that PTCL patients tend to have a poor prognosis associated with several initial risk factors. Moreover, the T-cell phenotype itself appears to have a significant impact on overall survival. Thus, standard CHOP chemotherapy may be inadequate for PTCLs, especially in patients with high-risk factors. The development of newly stratified therapies for the treatment of PTCLs would be highly desirable.

Для цитирования: Akagi Tomoaki, Takahashi Naoto, Yamaguchi Kouhei, Ishizawa Kenichi, Murai Kazunori, Tajima Katsushi, Ikeda Kazuhiko, Kameoka Yoshihiro, Kameoka Junnichi, Ito Shigeki, Kato Yuichi, Noji Hideyoshi, Shichishima Tsutomu, Itoh Jugoh, Ichinohasama Ryo, Harigae Hideo, Ishida Yoji, Sawada Kenichi. Comparison of long-term clinical outcomes of CHOP chemotherapy between Japanese patients with nodal peripheral T-cell lymphomas and those with diffuse large B-cell lymphoma in the study group of the Tohoku Hematology Forum.. Journal of clinical and experimental hematopathology : JCEH. 2011. DOI: 10.3960/jslrt.51.29.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.